Stocks
Theriva Biologics, Inc.TOVX
AMEXHealthcareBiotechnology$0.19
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for cancer and viral diseases, with a focus on oncolytic adenoviruses and microbiome-based treatments. Its lead candidates target solid tumors and are in early-to-mid-stage trials, making it a speculative play for investors monitoring novel immuno-oncology approaches.
52W Range: $0.16-$0.85
Congressional Interest in Theriva Biologics, Inc. (TOVX)
No congressional trades have been disclosed for Theriva Biologics, Inc. (TOVX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TOVX?
No congressional trades found for this stock.